Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals

• Cheryl A. Stoddart ,

  *To whom correspondence should be addressed. E-mail: cheryl.stoddart@ucsf.edu

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Cheryl A. Bales,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Jennifer C. Bare,

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• George Chkhenkeli,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Sofiya A. Galkina,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• April N. Kinkade,

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Mary E. Moreno,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• José M. Rivera,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Rollie E. Ronquillo,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Barbara Sloan,

  Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America

  Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Paul L. Black

  Affiliation Targeted Interventions Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯